Hologic (HOLX) Tops Q2 EPS by 21c; raises guidance

Hologic (NASDAQ: HOLX) reported Q2 EPS of $1.09, $0.21 better than the analyst estimate of $0.88. Revenue for the quarter came in at $1.03 billion versus the consensus estimate of $956.45 million.

GUIDANCE:

Hologic sees Q3 2023 EPS of $0.83-$0.93, versus the consensus of $0.88. Hologic sees Q3 2023 revenue of $930-980 million, versus the consensus of $959.5 million.

Hologic sees FY2023 EPS of $3.75-$3.95, versus the consensus of $3.75. Hologic sees FY2023 revenue of $3.925-4.025 billion, versus the consensus of $3.97 billion.

For earnings history and earnings-related data on Hologic (HOLX) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Cerebras Systems posts 94% revenue jump, announces OpenAI deal
• CVG to join Russell 2000 and Russell 3000 indexes June 26